Establishment of the human α-synuclein nuclear localization signal transgenic mice
10.3969/j.issn.1005-4847.2024.03.004
- VernacularTitle:核定位人源α-突触核蛋白转基因小鼠的建立
- Author:
Mengchen WEI
1
;
Shengtao FAN
;
Haiting WU
;
Yiwei ZHANG
;
Ziou WANG
;
Zhangqiong HUANG
Author Information
1. 北京协和医学院 中国医学科学院医学生物学研究所,昆明 650118
- Keywords:
human α-synuclein;
mouse;
nuclear localization;
transgenic;
motor dysfunction
- From:
Acta Laboratorium Animalis Scientia Sinica
2024;32(3):307-316
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish a human α-synuclein nuclear localization signal transgenic mouse model and investigate the effects of α-synuclein nuclear localization on the behavior of mice.Methods Human α-synuclein nuclear localization signal and EGFP lentiviral vectors were constructed.Transgenic mice were created with the microinjection method.Using PCR and Western Blot method to identify the genotypes and protein expression of the transgenic founder mice and their offsprings.The immunofluorescence was used to examine the localization of human α-synuclein in the mouse brain tissue.The behavioral changes of the transgenic mice were evaluated by the open field test,rotarod test,and O maze test.Results The h SNCA-NLS gene was successfully inserted into the mouse genome,the human α-syn was successfully expressed,and the human α-syn has localized with the nuclear.Further studies found that human α-synuclein nuclear localization signal transgenic mice had significant motor dysfunction,astrocyte proliferation and inflammatory response at 2 months of age and exhibited significant anxiety-like symptoms and reduced expression of the γ-aminobutyric acid(GABA)gene at 9 months of age,which persisted until 12 months of age.Conclusions A human α-synuclein nuclear localization signal transgenic mouse model has been successfully established.The mice exhibit significant motor dysfunction and anxiety-like symptoms.The successful establishment of this model provides a foundation for studying the role of α-syn nuclear localization in Parkinson's disease.
